SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. / Nilsson, Christa; Barrios-Lopez, Brianda; Kallinen, Annukka; Laurinmäki, Pasi; Butcher, Sarah J; Raki, Mari; Weisell, Janne; Bergström, Kim; Larsen, Susan Weng; Ostergaard, Jesper; Larsen, Claus; Urtti, Arto; Airaksinen, Anu J; Yaghmur, Anan.

In: Biomaterials, Vol. 34, No. 33, 07.08.2013, p. 8491-8503.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Nilsson, C, Barrios-Lopez, B, Kallinen, A, Laurinmäki, P, Butcher, SJ, Raki, M, Weisell, J, Bergström, K, Larsen, SW, Ostergaard, J, Larsen, C, Urtti, A, Airaksinen, AJ & Yaghmur, A 2013, 'SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications', Biomaterials, vol. 34, no. 33, pp. 8491-8503. https://doi.org/10.1016/j.biomaterials.2013.07.055

APA

Nilsson, C., Barrios-Lopez, B., Kallinen, A., Laurinmäki, P., Butcher, S. J., Raki, M., Weisell, J., Bergström, K., Larsen, S. W., Ostergaard, J., Larsen, C., Urtti, A., Airaksinen, A. J., & Yaghmur, A. (2013). SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. Biomaterials, 34(33), 8491-8503. https://doi.org/10.1016/j.biomaterials.2013.07.055

Vancouver

Nilsson C, Barrios-Lopez B, Kallinen A, Laurinmäki P, Butcher SJ, Raki M et al. SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. Biomaterials. 2013 Aug 7;34(33):8491-8503. https://doi.org/10.1016/j.biomaterials.2013.07.055

Author

Nilsson, Christa ; Barrios-Lopez, Brianda ; Kallinen, Annukka ; Laurinmäki, Pasi ; Butcher, Sarah J ; Raki, Mari ; Weisell, Janne ; Bergström, Kim ; Larsen, Susan Weng ; Ostergaard, Jesper ; Larsen, Claus ; Urtti, Arto ; Airaksinen, Anu J ; Yaghmur, Anan. / SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications. In: Biomaterials. 2013 ; Vol. 34, No. 33. pp. 8491-8503.

Bibtex

@article{05679d0c349c48ae8ac83358a2da98cf,
title = "SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications",
abstract = "We have developed a highly efficient method for the radiolabeling of phytantriol (PHYT)/oleic acid (OA)-based hexosomes based on the surface chelation of technetium-99m ((99m)Tc) to preformed hexosomes using the polyamine 1, 12-diamino-3, 6, 9-triazododecane (SpmTrien) as chelating agent. We also report on the unsuccessful labeling of cubosomes using the well-known chelating agent hexamethylpropyleneamine oxime (HMPAO). The (99m)Tc-labeled SpmTrien-hexosomes ((99m)Tc-SpmTrien-hexosomes) were synthesized with good radiolabeling (84%) and high radiochemical purity (>90%). The effect of radiolabeling on the internal nanostructure and the overall size of these aqueous dispersions was investigated by using synchrotron small angle X-ray scattering (SAXS), dynamic light scattering (DLS), and transmission electron cryo microscopy (cryo-TEM). Further, we show the utility of (99m)Tc-SpmTrien-hexosomes for the in vivo imaging of healthy mice using single photon emission computed tomography (SPECT) in combination with computed tomography (CT), i.e. SPECT/CT. SPECT/CT experiments of subcutaneously administered (99m)Tc-SpmTrien-hexosomes to the flank of mice showed a high stability in vivo allowing imaging of the distribution of the radiolabeled hexosomes for up to 24 h. These injected (99m)Tc-SpmTrien-hexosomes formed a deposit within the subcutaneous adipose tissue, displaying a high biodistribution of ∼343% injected dose/g tissue (%ID/g), with negligible uptake in other organs and tissues. The developed (99m)Tc labeling method for PHYT/OA-based hexosomes could further serve as a useful tool for investigating and imaging the in vivo performance of cubosomal and hexosomal drug nanocarriers.",
author = "Christa Nilsson and Brianda Barrios-Lopez and Annukka Kallinen and Pasi Laurinm{\"a}ki and Butcher, {Sarah J} and Mari Raki and Janne Weisell and Kim Bergstr{\"o}m and Larsen, {Susan Weng} and Jesper Ostergaard and Claus Larsen and Arto Urtti and Airaksinen, {Anu J} and Anan Yaghmur",
note = "{\textcopyright} 2013 Elsevier Ltd. All rights reserved.",
year = "2013",
month = aug,
day = "7",
doi = "10.1016/j.biomaterials.2013.07.055",
language = "English",
volume = "34",
pages = "8491--8503",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier",
number = "33",

}

RIS

TY - JOUR

T1 - SPECT/CT imaging of radiolabeled cubosomes and hexosomes for potential theranostic applications

AU - Nilsson, Christa

AU - Barrios-Lopez, Brianda

AU - Kallinen, Annukka

AU - Laurinmäki, Pasi

AU - Butcher, Sarah J

AU - Raki, Mari

AU - Weisell, Janne

AU - Bergström, Kim

AU - Larsen, Susan Weng

AU - Ostergaard, Jesper

AU - Larsen, Claus

AU - Urtti, Arto

AU - Airaksinen, Anu J

AU - Yaghmur, Anan

N1 - © 2013 Elsevier Ltd. All rights reserved.

PY - 2013/8/7

Y1 - 2013/8/7

N2 - We have developed a highly efficient method for the radiolabeling of phytantriol (PHYT)/oleic acid (OA)-based hexosomes based on the surface chelation of technetium-99m ((99m)Tc) to preformed hexosomes using the polyamine 1, 12-diamino-3, 6, 9-triazododecane (SpmTrien) as chelating agent. We also report on the unsuccessful labeling of cubosomes using the well-known chelating agent hexamethylpropyleneamine oxime (HMPAO). The (99m)Tc-labeled SpmTrien-hexosomes ((99m)Tc-SpmTrien-hexosomes) were synthesized with good radiolabeling (84%) and high radiochemical purity (>90%). The effect of radiolabeling on the internal nanostructure and the overall size of these aqueous dispersions was investigated by using synchrotron small angle X-ray scattering (SAXS), dynamic light scattering (DLS), and transmission electron cryo microscopy (cryo-TEM). Further, we show the utility of (99m)Tc-SpmTrien-hexosomes for the in vivo imaging of healthy mice using single photon emission computed tomography (SPECT) in combination with computed tomography (CT), i.e. SPECT/CT. SPECT/CT experiments of subcutaneously administered (99m)Tc-SpmTrien-hexosomes to the flank of mice showed a high stability in vivo allowing imaging of the distribution of the radiolabeled hexosomes for up to 24 h. These injected (99m)Tc-SpmTrien-hexosomes formed a deposit within the subcutaneous adipose tissue, displaying a high biodistribution of ∼343% injected dose/g tissue (%ID/g), with negligible uptake in other organs and tissues. The developed (99m)Tc labeling method for PHYT/OA-based hexosomes could further serve as a useful tool for investigating and imaging the in vivo performance of cubosomal and hexosomal drug nanocarriers.

AB - We have developed a highly efficient method for the radiolabeling of phytantriol (PHYT)/oleic acid (OA)-based hexosomes based on the surface chelation of technetium-99m ((99m)Tc) to preformed hexosomes using the polyamine 1, 12-diamino-3, 6, 9-triazododecane (SpmTrien) as chelating agent. We also report on the unsuccessful labeling of cubosomes using the well-known chelating agent hexamethylpropyleneamine oxime (HMPAO). The (99m)Tc-labeled SpmTrien-hexosomes ((99m)Tc-SpmTrien-hexosomes) were synthesized with good radiolabeling (84%) and high radiochemical purity (>90%). The effect of radiolabeling on the internal nanostructure and the overall size of these aqueous dispersions was investigated by using synchrotron small angle X-ray scattering (SAXS), dynamic light scattering (DLS), and transmission electron cryo microscopy (cryo-TEM). Further, we show the utility of (99m)Tc-SpmTrien-hexosomes for the in vivo imaging of healthy mice using single photon emission computed tomography (SPECT) in combination with computed tomography (CT), i.e. SPECT/CT. SPECT/CT experiments of subcutaneously administered (99m)Tc-SpmTrien-hexosomes to the flank of mice showed a high stability in vivo allowing imaging of the distribution of the radiolabeled hexosomes for up to 24 h. These injected (99m)Tc-SpmTrien-hexosomes formed a deposit within the subcutaneous adipose tissue, displaying a high biodistribution of ∼343% injected dose/g tissue (%ID/g), with negligible uptake in other organs and tissues. The developed (99m)Tc labeling method for PHYT/OA-based hexosomes could further serve as a useful tool for investigating and imaging the in vivo performance of cubosomal and hexosomal drug nanocarriers.

U2 - 10.1016/j.biomaterials.2013.07.055

DO - 10.1016/j.biomaterials.2013.07.055

M3 - Journal article

C2 - 23932247

VL - 34

SP - 8491

EP - 8503

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 33

ER -

ID: 49142021